Your browser doesn't support javascript.
loading
Bendamustine in combination with thalidomide and dexamethasone is a viable salvage option in myeloma relapsed and/or refractory to bortezomib and lenalidomide.
Lau, I-Jun; Smith, Dean; Aitchison, Robin; Blesing, Norbert; Roberts, Pamela; Peniket, Andrew; Yong, Kwee; Rabin, Neil; Ramasamy, Karthik.
Affiliation
  • Lau IJ; Level 2, Cancer and Hematology Centre, Churchill Hospital, Oxford University Hospitals NHS Trust, Oxford, OX3 7LE, UK, ijunlau@doctors.org.uk.
Ann Hematol ; 94(4): 643-9, 2015 Apr.
Article in En | MEDLINE | ID: mdl-25345871
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrazines / Thalidomide / Boronic Acids / Dexamethasone / Antineoplastic Combined Chemotherapy Protocols / Salvage Therapy / Multiple Myeloma / Nitrogen Mustard Compounds Type of study: Observational_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Ann Hematol Journal subject: HEMATOLOGIA Year: 2015 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrazines / Thalidomide / Boronic Acids / Dexamethasone / Antineoplastic Combined Chemotherapy Protocols / Salvage Therapy / Multiple Myeloma / Nitrogen Mustard Compounds Type of study: Observational_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Ann Hematol Journal subject: HEMATOLOGIA Year: 2015 Document type: Article